2020 Myeloma

Scheme description
Sample or online analysis to detect recurrent abnormalities associated with myeloma. Interphase FISH, array or NGS can be undertaken on the sample.
Disorders/Gene target(s)
Myeloma clinical case scenarios
Clinical cases
Two
Testing/analysis
Detection of recurrent abnormalities and/or testing of whole genome copy number changes and structural rearrangements.
Sample type
One to two fixed cell samples and DNA sample (on request)
OR
Online case with FISH images for analysis
Techniques
Any methodology including FISH, array, NGS
Assessment
Submit a clinical report to include:
● Analysis of results
● Interpretation of the result
● Clerical accuracy
Performance criteria are applied.
Eligibility
All laboratories worldwide
Languages
English, German, Italian, Spanish, French
ISO17043 Accredited EQA
Yes
EQA timeline
Sample dispatchAugust 2020
Testing period5 weeks
Assessment resultsDecember 2020
Final Summary reportFebruary 2021
Other information
Fee
£375.00
GenQA code
2020M
« Return to EQA scheme list
Go to top